2022
DOI: 10.1016/j.ijregi.2021.12.008
|View full text |Cite
|
Sign up to set email alerts
|

Seroprevalence of SARS-CoV-2 IgG antibodies in a healthcare setting during the first pandemic wave in Senegal

Abstract: This study describes the seroprevalence of SARS-CoV-2 IgG during the first wave in Senegal. The study aimed to identify the seroprevalence rate of SARS-CoV-2 IgG in 10 cities throughout Senegal by testing plasma from volunteers attending healthcare clinics for non-COVID-19 related reasons ( n = 3231) collected between June and October of 2020. The overall positivity rate was 20.4% and large geographical differences in seropositivity (6-41.9%) were observed, suggesting that the true numbe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 1 publication
0
4
0
Order By: Relevance
“…conducted a study between June and October 2020. They found that the overall positivity rate was 20.4% and significant geographical differences in seropositivity with a higher seroprevalence in Dakar, around 40% [38]. Then, Talla et al found an adjusted national prevalence of anti-SARS-CoV-2 IgG/IgM in Senegal estimated to be 28.4% between October 24 and November 26, 2020 [39].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…conducted a study between June and October 2020. They found that the overall positivity rate was 20.4% and significant geographical differences in seropositivity with a higher seroprevalence in Dakar, around 40% [38]. Then, Talla et al found an adjusted national prevalence of anti-SARS-CoV-2 IgG/IgM in Senegal estimated to be 28.4% between October 24 and November 26, 2020 [39].…”
Section: Discussionmentioning
confidence: 99%
“…The very IgG high seroprevalence could be due to increased exposure to the SARS-CoV-2 virus and the anti-COVID vaccination policy implemented by the authorities. They found that the overall positivity rate was 20.4% and significant geographical differences in seropositivity with a higher seroprevalence in Dakar, around 40% [38].…”
Section: Risk Factors Associated With Sars-covmentioning
confidence: 99%
“…As early as April 2020, the Africa Centers for Disease Control and Prevention called attention to the lack of SARS-CoV-2 diagnostics in the region (10). Indeed, serological surveys from multiple countries revealed infection burdens much higher than those predicted based on case-based surveillance, an indication of underdiagnosis of COVID-19 cases by diagnostic systems (11)(12)(13). Testing is an integral part of the COVID-19 responses of sub-Saharan African countries (14), and the lack of adequate testing capacity can impede public health efforts.…”
Section: Introductionmentioning
confidence: 99%
“…As early as April 2020, the Africa Centers for Disease Control and Prevention called attention to the lack of SARS-CoV-2 diagnostics in the region (3). Indeed, serological surveys from multiple countries revealed infection burdens much higher than those predicted from case-based surveillance, an indication of underdiagnosis of SARS-CoV-2 cases by diagnostic systems (46). Testing is an integral part of the COVID-19 responses of sub-Saharan African countries (7), and the lack of adequate testing capacity is an impediment to public health efforts.…”
Section: Introductionmentioning
confidence: 99%